Investigators’ response
Clinical and Translational Radiation Oncology, vol. 59, pp. 101167
Abstract
We have read the Letter to the Editor of Lamba et al. with great interest and appreciate their thoughtful and constructive comments. Their observations, together with our findings, underline the importance of employing more comprehensive methodologies to evaluate bone marrow sparing techniques and their impact on the immune system. In this response, we elaborate on the points raised and add our perspective to further contribute to this valuable discussion.
Authors 5
-
Leiden University Medical Center · Erasmus MC · Erasmus MC Cancer Institute
Affiliation as printed
Department of Radiation Oncology, Leiden University Medical Center, Leiden, The Netherlands
Department of Radiotherapy, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands
-
Leiden University Medical Center · Oncode Institute
Affiliation as printed
Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands
Oncode Institute, Jaarbeursplein 6, 3521 AL Utrecht, The Netherlands
-
Leiden University Medical Center
Affiliation as printed
Department of Radiation Oncology, Leiden University Medical Center, Leiden, The Netherlands
-
Leiden University Medical Center · Oncode Institute
Affiliation as printed
Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands
Oncode Institute, Jaarbeursplein 6, 3521 AL Utrecht, The Netherlands
-
Leiden University Medical Center
Affiliation as printed
Department of Radiation Oncology, Leiden University Medical Center, Leiden, The Netherlands
Cited by 0 stored of 0
No patents citing this paper on Lens.org (checked 2026-10-11).